Press release
Sickle Cell Anemia Therapeutics Market to Witness a Pronounce Growth During 2026
The Sickle Cell Anemia Treatment Market was valued at US$2.26 billion in the year 2018 and is estimated to reach US$6.46 billion by 2026, at a CAGR of 14.05%.Sickle Cell Anemia is an autosomal recessive disorder caused by a mutation in the hemoglobin-β gene found on chromosome 11, due to which the red blood cells become sickle or crescent moon shaped and get stuck in small blood vessels. This can result in slow blood flow and hypoxia condition. The signs and symptoms of sickle cell anemia include anemia, pain episodes and swelling of hands & feet, frequent infections, vision problems and delayed growth in infants, children & delay puberty in teenagers. Sickle Cell Anemia results in complications like stroke, Acute chest syndrome, pulmonary hypertension and organ damage.
The worldwide prevalence of sickle cell anemia is estimated to be 3.2 million and around 85% of cases are reported in Africa, in 2017. According to WHO, trait genes for hemoglobin disorders mainly, sickle-cell disease and thalassemia are carried by 5% of the world’s population. Every year around 300,000 babies are born with severe hemoglobin disorders. The prevalence of the sickle-cell trait (healthy carriers who have inherited the mutant gene from only one parent) ranges between 10% and 40% across Africa.
The major market drivers include increase prevalence of sickle cell anemia, rise in development of genetic therapies, growing product pipeline and orphan disease status for the treatment of the sickle cell anemia treatment. Adverse effects, lack of awareness and diagnosis of sickle cell anemia, high treatment cost and lack of approved therapies are the major market restraints for the sickle cell anemia treatment market.
Investments in R&D, development of novel advanced effective medications and rise in demand for proper treatment might impact the market growth positively in the forecast period. To meet the critical need of patients, approval of fast frack, orphan drug and rare disease designations will be given, which might boost the sickle cell anemia treatment market during the forecast period
Major companies for the Treatment of Sickle Cell Anemia include Bristol-Myers Squibb, Novartis, Pfizer, Emmaus Life Sciences, Bluebird Bio, Takeda Pharmaceuticals, Global Blood Therapeutic Inc, CSL Behring. According to clinicaltrials.gov, there are around 200 active interventional trials for the treatment of Sickle Cell Anemia at present.
Recent Updates
Currently, Pfizer is conducting research on new molecular entity PF-04447943 for the treatment of sickle cell anemia
Bluebird Bio announced continuing promising results of LentiGlobin, investigational gene therapy for sickle cell disease
CRISPR Therapeutics is developing CTX001, investigational therapy to treat inherited disorders of hemoglobin such as sickle cell disease and beta-thalassemia
Sickle Cell Anemia Treatment Market Based on Treatment Class (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn):
• Blood Transfusion
• Pharmacotherapy
• Antibiotics
• Analgesics
• Antimetabolite (Hydroxy Urea)
• Bone Marrow Transplantation
• Gene Therapy
Sickle Cell Anemia Treatment Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
• North America
• Europe
• APAC
• LAMEA
Request for Sample Pages @ https://www.optimainsights.org/sample-request/151-sickle-cell-anemia-therapeutics-market
Research Scope
Provides a detailed Analysis of the Market Structure along with forecast of the various segments and sub-segments.
Provides a Comparative Analysis of Key Marketed and Pipeline Products.
Provides Key Information on Players involved.
Provides a Complete Overview of Market Segments and the Regional Outlook.
Provides In-depth Coverage of Key News, including Major Mergers, Acquisitions and Product Development updates such as clinical trial progression updates and regulatory updates.
The Report Provides Key Insights on
History of the Sickle Cell Anemia Treatment Market, 2015 to 2017
Forecast of the Sickle Cell Anemia Treatment Market Growth till the year 2026
The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Sickle Cell Anemia Treatment Market
Analysis of potential growth segments which will drive the market
Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market
Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics
Download Complete TOC of the Report @ https://www.optimainsights.org/request-toc/151-sickle-cell-anemia-therapeutics-market
Contact
Optima Insights
Mr. Chucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
Email: sales@optimainsights.org
https://www.optimainsights.org
206, City Tower Complex, Kothapet, Hyderabad - 35 Telangana, I N D I A
Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sickle Cell Anemia Therapeutics Market to Witness a Pronounce Growth During 2026 here
News-ID: 1883877 • Views: …
More Releases from Optima Insights Pvt. Ltd.

Market Research Report on Global Orthotic Devices Market Outlook to 2026
Orthotics can be characterized as the brace, support or splint used to align, prevent, support or to address the working of versatile body parts, for example, knee, wrist, shoulder, neck and so on. The medical field which manages the design and assembling of these devices is known as Orthotics. The orthotic devices are fundamentally used to defeat from the disabling illness, congenital condition or traumatic injury. The Overall Global Orthotic…
Neurodegenerative Disease Market Trends, Opportunities and Challenges in 2026
Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and/or death of nerve cells. This causes problems with movement (Ataxia), or mental functioning (dementia). The overall Global Neurodegenerative Disease Market is expected to grow at a significant compound CAGR rate of 6.8% from USD 32.65 billion in 2018 to USD 55.26 billion in 2026. This expansion in neurodegenerative disease is due to the ascending public awareness and…

Global Breast Cancer Treatment Market Expected to Reach $45.52 bn by 2026
The incidence of breast cancer is higher in urban areas, especially the metropolitan cities where it is now the leading female cancer and is the second most common cancer after cervix in rural and semi-urban areas. As for other cancers, late-stage presentation is also a common scenario for breast cancer. The overall Global Breast Cancer Treatment Market is expected to grow at a significant compound CAGR rate of 12.9% from…

Global Vaccine Adjuvants Market: Competitive Dynamics & Global Outlook 2026
Vaccine Adjuvant has developed into a significant segment for the vast majority of the clinically utilized immunizations. Adjuvant assistances to activate the immune system and license the antigens pathogen constituents that reason for immune response in vaccines to prompt long period protective immunity. It improves immunology by anticipating body against irresistible illnesses for a longer time and the key material that is communicated as a part of the vaccine, which…
More Releases for Anemia
Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period?
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM.
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,…
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435
This latest report researches the industry structure,…
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022
Global Anemia Drugs Market - Segments
Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;…
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,…
Global Anemia in Chronic Kidney Disease (Renal Anemia) Clinical Trials Market Re …
Market Research Hub's clinical trial report, Global Anemia in Chronic Kidney Disease (Renal Anemia) Clinical Trials Review, H1, 2017, provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic Kidney Disease (Renal Anemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
Request…